Alternative futures for laboratory medicine in 2050: scenarios and signposts for diagnostic capability contraction

INTRODUCTION: Laboratory medicine has begun to describe its own future, and the images it produces are almost uniformly expansionary. What they rarely contain is a collapse scenario: a future in which the field delivers less than today. A profession planning for 2050 needs one. CONTENT: We summarise what structured foresight offers a clinical readership, entering through the threats quadrant of a strengths, weaknesses, opportunities and threats (SWOT) analysis, and treat the standard taxonomy of futures as a lens, not a required method. We define diagnostic capability contraction as progressive degradation rather than catastrophic disappearance, distinct from retiring tests that add nothing. Six drivers are specified: loss of laboratory-developed tests, reduced test availability, workforce attrition, supplier dependency, geographical access and payment. Evidence comes from three jurisdictions, including Japan, where one regulatory driver produced different outcomes in the same period. We set out four scenarios for 2050, one per generic image, and propose signposts as early-warning indicators, with action thresholds, for the contraction scenario. Estimates of likelihood attach to the indicators, not the futures. SUMMARY: The evidence base is uneven across drivers, and informatively so: what is not anticipated is not measured. The argument applies to our own prior work, expansionary in the same way. OUTLOOK: A set containing a contraction branch gives laboratory leadership what an expansionary set cannot: what to watch for, and when to act. A preferred future chosen without it comes from a shorter list than the field faces. Building a balanced set is work that no small group of authors can do alone.

Authors

Institutions

Publication Details

Journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2026-09-11
DOI
https://doi.org/10.1515/cclm-2026-1377
Primary Topic
Clinical Laboratory Practices and Quality Control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Alternative futures for laboratory medicine in 2050: scenarios and signposts for diagnostic capability contraction

Wakako Yuji, Koichiro Yuji, Hiroaki Ohnishi
Clinical Chemistry and Laboratory Medicine (CCLM)
Clinical Laboratory Practices and Quality Control
article

Alternative futures for laboratory medicine in 2050: scenarios and signposts for diagnostic capability contraction

Wakako Yuji, Koichiro Yuji, Hiroaki Ohnishi
article en

Abstract

INTRODUCTION: Laboratory medicine has begun to describe its own future, and the images it produces are almost uniformly expansionary. What they rarely contain is a collapse scenario: a future in which the field delivers less than today. A profession planning for 2050 needs one. CONTENT: We summarise what structured foresight offers a clinical readership, entering through the threats quadrant of a strengths, weaknesses, opportunities and threats (SWOT) analysis, and treat the standard taxonomy of futures as a lens, not a required method. We define diagnostic capability contraction as progressive degradation rather than catastrophic disappearance, distinct from retiring tests that add nothing. Six drivers are specified: loss of laboratory-developed tests, reduced test availability, workforce attrition, supplier dependency, geographical access and payment. Evidence comes from three jurisdictions, including Japan, where one regulatory driver produced different outcomes in the same period. We set out four scenarios for 2050, one per generic image, and propose signposts as early-warning indicators, with action thresholds, for the contraction scenario. Estimates of likelihood attach to the indicators, not the futures. SUMMARY: The evidence base is uneven across drivers, and informatively so: what is not anticipated is not measured. The argument applies to our own prior work, expansionary in the same way. OUTLOOK: A set containing a contraction branch gives laboratory leadership what an expansionary set cannot: what to watch for, and when to act. A preferred future chosen without it comes from a shorter list than the field faces. Building a balanced set is work that no small group of authors can do alone.

Clinical Chemistry and Laboratory Medicine (CCLM)
Kyorin University (JP), Tokyo Health Care University (JP), University of Tokyo Hospital (JP), Saitama International Medical Center (JP), Kitasato Institute Hospital (JP)
Openalex Percentile: Top 11%
Clinical Laboratory Practices and Quality Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.